IN2014DN08588A - - Google Patents

Info

Publication number
IN2014DN08588A
IN2014DN08588A IN8588DEN2014A IN2014DN08588A IN 2014DN08588 A IN2014DN08588 A IN 2014DN08588A IN 8588DEN2014 A IN8588DEN2014 A IN 8588DEN2014A IN 2014DN08588 A IN2014DN08588 A IN 2014DN08588A
Authority
IN
India
Prior art keywords
1himidazol
benzenamine
trifluoromethyl
safe
prepare
Prior art date
Application number
Inventor
Stephan Abel
Murat Acemoglu
Bernhard Erb
Christoph Krell
Joseph Sclafani
Mark Meisenbach
Mahavir Prashad
Wen-Chung Shieh
Song Xue
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN08588(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IN2014DN08588A publication Critical patent/IN2014DN08588A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention provides an efficient, safe and cost effective way to prepare 5-(4-methyl-1Himidazol- l-yl)-3- (trifluoromethyl)-benzenamine which is a key intermediate for the preparation of substituted pyrimidinylaminobenzamides of formula (11).
IN8588DEN2014 2005-06-09 2006-06-07 IN2014DN08588A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09
PCT/US2006/022154 WO2006135640A2 (en) 2005-06-09 2006-06-07 Process for the synthesis of organic compounds

Publications (1)

Publication Number Publication Date
IN2014DN08588A true IN2014DN08588A (en) 2015-07-10

Family

ID=37149980

Family Applications (2)

Application Number Title Priority Date Filing Date
IN8588DEN2014 IN2014DN08588A (en) 2005-06-09 2006-06-07
IN8578DEN2014 IN2014DN08578A (en) 2005-06-09 2006-06-07

Family Applications After (1)

Application Number Title Priority Date Filing Date
IN8578DEN2014 IN2014DN08578A (en) 2005-06-09 2006-06-07

Country Status (25)

Country Link
US (2) US7781597B2 (en)
EP (3) EP1896426B1 (en)
JP (2) JP5225078B2 (en)
KR (2) KR101249199B1 (en)
CN (6) CN102180796A (en)
AR (1) AR057056A1 (en)
AT (1) ATE540931T1 (en)
AU (3) AU2006258050B2 (en)
BR (1) BRPI0611683A2 (en)
CA (4) CA2833394C (en)
DK (2) DK2292607T3 (en)
ES (3) ES2380489T3 (en)
GT (1) GT200600202AA (en)
HU (1) HUE028024T2 (en)
IN (2) IN2014DN08588A (en)
JO (1) JO2758B1 (en)
MX (1) MX2007015609A (en)
MY (1) MY146795A (en)
PE (3) PE20070109A1 (en)
PL (3) PL1896426T3 (en)
PT (3) PT2292607E (en)
RU (1) RU2446162C2 (en)
SI (2) SI2292607T1 (en)
TW (1) TWI380981B (en)
WO (1) WO2006135640A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4883296B2 (en) 2004-03-05 2012-02-22 日産化学工業株式会社 Isoxazoline-substituted benzamide compounds and pest control agents
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (en) 2005-12-30 2013-10-21 Du Pont Isoxazolines for controlling invertebrate pests
JP5473906B2 (en) 2007-06-13 2014-04-16 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー Isoxazoline insecticide
TWI430995B (en) 2007-06-26 2014-03-21 Du Pont Naphthalene isoxazoline invertebrate pest control agents
JP6006471B2 (en) 2007-06-27 2016-10-12 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーＥ．Ｉ．Ｄｕ Ｐｏｎｔ Ｄｅ Ｎｅｍｏｕｒｓ Ａｎｄ Ｃｏｍｐａｎｙ Animal pest control methods
TWI649303B (en) 2007-08-17 2019-02-01 杜邦股份有限公司 Compound and method for preparing 4-acetyl-n-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-1-naphthalenecarboxamide
AU2008308907B2 (en) 2007-10-03 2014-08-14 Corteva Agriscience Llc Naphthalene isoxazoline compounds for control of invertebrate pests
TWI455919B (en) * 2008-04-09 2014-10-11 Du Pont Method for preparing 3-trifluoromethylchalcone (CHALCONE)
EP2305667A3 (en) 2008-07-17 2011-05-11 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
EP2262793B1 (en) 2008-11-05 2012-10-03 Teva Pharmaceutical Industries Ltd. Nilotinib hci crystalline forms
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
US20110053968A1 (en) * 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
UA108881C2 (en) 2010-05-27 2015-06-25 CRYSTAL FORM 4- $ 5- $ 3-CHLORINE-5- (TRIFLUOROMETHYL) PHENYL] -4,5-DIHYDRO-5- (TRIFLUORMETHYL) -3-ISOXAZOLYL] -N- $ 2-OXO-2 - $ 2,2 -TRIFLUOROTHYL) AMINO] ETHYL] -1-NAPHTHALINE CARBOXAMIDE
DK2797927T3 (en) 2011-12-30 2019-10-28 Hanmi Pharm Ind Co Ltd THIENO [3,2-d] PYRIMIDINE DERIVATIVES WHICH HAVE INHIBITORIAL ACTIVITY FOR PROTEINKINASE
CN102592837B (en) * 2012-03-12 2014-01-15 河北师范大学 Method for preparing polyaniline electrode doped with tetrachloride metal quaternary ammonium salt for supercapacitor
CN103694176B (en) 2014-01-07 2015-02-18 苏州立新制药有限公司 Preparation method of nilotinib intermediate
CN104592122B (en) * 2014-12-09 2018-01-23 凯莱英医药集团（天津）股份有限公司 The preparation method of 3 (base of 4 methyl 1H imidazoles 1) 5 (trifluoromethyl) aniline
CN105985293B (en) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 The preparation method of AMN107 intermediate
EP3095782A1 (en) 2015-05-18 2016-11-23 Esteve Química, S.A. New method for preparing 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CN107201532B (en) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 The nitration method of aromatic compound
US11053220B2 (en) 2018-01-01 2021-07-06 Laurus Labs Ltd Process for 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (en) 2018-04-10 2020-01-21 江苏创诺制药有限公司 Crystal form of 3- (4-methyl-1H-imidazole-1-yl) -5-trifluoromethyl aniline monohydrochloride and application thereof
JP7409696B2 (en) 2018-06-15 2024-01-09 ハンダ ファーマシューティカルズ インコーポレイテッド Kinase inhibitor salts and compositions thereof
WO2020210174A2 (en) * 2019-04-06 2020-10-15 Trinapco, Inc. Sulfonyldiazoles and n-(fluorosulfonyl)azoles, and methods of making the same
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride
CN114751836B (en) * 2021-02-23 2024-05-31 四川青木制药有限公司 Synthesis method and intermediate of 3- (4-methyl-1H-imidazol-1-yl) -5- (trifluoromethyl) aniline
CN114853734A (en) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 A kind of preparation method of Nilotinib free base
CN116478319B (en) * 2022-11-07 2025-07-01 华北电力大学 Preparation method of an ionic covalent organic polymer and its application in adsorbing ReO4- in an alkaline environment
CN115626880B (en) * 2022-11-15 2023-11-14 常州大学 Synthesis method of 3-nitro-5-cyano benzotrifluoride
CN118108670B (en) * 2023-12-28 2025-07-01 江苏希迪制药有限公司 Purification method of nilotinib intermediate 3- (4-methyl-1H-imidazol-1-yl) -5- (trifluoromethyl) aniline

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (en) * 1982-04-09 1983-10-30 Алтайский политехнический институт Process for preparing imidazole derivatives
GR851296B (en) * 1984-05-29 1985-11-25 Pfizer
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (en) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals AMIDA COMPOSITE AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINASES, AND THE INSTRUCTIONS FOR USE
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
AR037647A1 (en) 2002-05-29 2004-12-01 Novartis Ag USED DIARILUREA DERIVATIVES FOR THE TREATMENT OF DEPENDENT DISEASES OF THE PROTEIN KINase
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) * 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (en) * 2004-12-31 2007-04-04 孙飘扬 Amino-metadiazine compound and its salt, its preparation and pharmaceutical use
GT200600207A (en) * 2005-06-09 2007-01-15 Novartis Ag PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds

Also Published As

Publication number Publication date
MX2007015609A (en) 2008-02-25
CN102174021A (en) 2011-09-07
CN102174020B (en) 2012-11-07
DK2266961T3 (en) 2016-01-25
AU2010241374A1 (en) 2010-12-02
TW200716563A (en) 2007-05-01
TWI380981B (en) 2013-01-01
RU2007148238A (en) 2009-07-20
KR20120099028A (en) 2012-09-06
US8008504B2 (en) 2011-08-30
EP1896426B1 (en) 2012-01-11
CA2886482A1 (en) 2006-12-21
CN101189212A (en) 2008-05-28
CN102180836A (en) 2011-09-14
US7781597B2 (en) 2010-08-24
CA2833394C (en) 2016-03-29
EP2292607A2 (en) 2011-03-09
PE20070109A1 (en) 2007-04-02
PL2292607T3 (en) 2014-09-30
KR101283109B1 (en) 2013-07-05
CA2611280C (en) 2014-01-28
AU2010241374B2 (en) 2011-11-03
MY146795A (en) 2012-09-28
EP2292607A3 (en) 2011-04-27
IN2014DN08578A (en) 2015-07-10
KR20080014010A (en) 2008-02-13
CA2833394A1 (en) 2006-12-21
CN102180836B (en) 2012-11-21
PL1896426T3 (en) 2012-06-29
EP2266961A2 (en) 2010-12-29
GT200600202AA (en) 2014-06-09
CN102174019A (en) 2011-09-07
AU2006258050B2 (en) 2010-12-09
CN102174020A (en) 2011-09-07
EP2266961B1 (en) 2015-10-21
SI2266961T1 (en) 2016-02-29
RU2446162C2 (en) 2012-03-27
JO2758B1 (en) 2014-03-15
CA2611280A1 (en) 2006-12-21
US20100280257A1 (en) 2010-11-04
CN102180796A (en) 2011-09-14
AU2011201044A1 (en) 2011-03-31
KR101249199B1 (en) 2013-04-03
EP2292607B1 (en) 2014-04-09
CN101189212B (en) 2011-05-18
WO2006135640A2 (en) 2006-12-21
WO2006135640A3 (en) 2007-08-02
BRPI0611683A2 (en) 2010-09-28
PT2292607E (en) 2014-06-24
EP1896426A2 (en) 2008-03-12
PT1896426E (en) 2012-04-12
JP2013035855A (en) 2013-02-21
CA2942046A1 (en) 2006-12-21
PE20100715A1 (en) 2010-10-25
ES2465522T3 (en) 2014-06-06
DK2292607T3 (en) 2014-06-30
AR057056A1 (en) 2007-11-14
PE20100716A1 (en) 2010-10-25
PL2266961T3 (en) 2016-04-29
AU2006258050A1 (en) 2006-12-21
EP2266961A3 (en) 2011-07-27
ATE540931T1 (en) 2012-01-15
CN102174019B (en) 2013-02-13
ES2380489T8 (en) 2012-06-22
JP2008546645A (en) 2008-12-25
CN102174021B (en) 2013-02-27
HUE028024T2 (en) 2016-11-28
PT2266961E (en) 2016-02-05
JP5225078B2 (en) 2013-07-03
ES2558696T3 (en) 2016-02-08
ES2380489T3 (en) 2012-05-14
CA2886482C (en) 2017-09-05
SI2292607T1 (en) 2014-09-30
US20080200692A1 (en) 2008-08-21

Similar Documents

Publication Publication Date Title
IN2014DN08588A (en)
WO2009016462A3 (en) Substituted bicyclolactam compounds
WO2007085895A3 (en) Fap inhibitors
TW200626559A (en) Anilino-pyrimidine analogs
WO2007105058A8 (en) Pyrazole compounds
WO2007106192A3 (en) Inhibitors of iap
MX2007011023A (en) 2- (4-0x0-4h-quinaz0lin-3-yl) acetamides and their use as vasopressin v3 antagonists.
MX2010002938A (en) (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1- carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating.
DK1696905T3 (en) Substituted 2-aminotetralines for the prophylactic treatment of Morbus Parkinson
TW200745039A (en) Isotopically substituted pantoprazole
EP1740559A4 (en) 1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
WO2007062308A3 (en) Homo- and heterocyclic compounds suitable as cetp inhibitors
WO2007019191A3 (en) Thiazolopyrimidine kinase inhibitors
WO2005087724A3 (en) Sulphonylpyrroles as hdac inhibitors
GB0510143D0 (en) Novel compounds A1
TW200624426A (en) BACE inhibitors
TW200710084A (en) Process for the synthesis of organic compounds
MY145788A (en) Antitumoral dihydropyran-2-one compounds
GB0521508D0 (en) Organic compounds
TNSN06260A1 (en) Process for the preparation of tryptase inhibitors
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
NZ595579A (en) 5-Difluoromethoxy-4-hydroxymethyl-1-methyl-3-trifluoromethyl-pyrazole / (5-(difluoromethoxy)-3-(trifluoromethyl)-1-methyl-1H-pyrazol-4-yl)methanol
WO2008019030A8 (en) Modified azole compounds as antiinfective agents
MXPA02012400A (en) Hetaryl-substituted heterocycles.
RS20060195A (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors